Biogen ALS drug considered not effective by FDA advisory panel

Biogen Inc. BIIB, received a setback late Wednesday after a Food and Drug Administration advisory committee said the biotech drug maker’s proposed amyotrophic lateral sclerosis, or ALS, treatment did not show it was effective. On Wednesday, the FDA’s Peripheral and Central Nervous System Drugs…#biogeninc #als #fda #toferson #biogen
Source: Reuters: Health - Category: Consumer Health News Source Type: news